Journal of Urgent Care Medicine

New RSV Vaccine Approved For Infants

The Food and Drug Administration this month approved a new vaccine for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants, designed as preventive care for their first RSV season. The long-acting monoclonal antibody clesrovimab-cfor offers protection through 5 months with the same 105 mg dose regardless of weight, according to a press release from manufacturer Merck. Clinical data from multiple trials shows significant reductions in RSV incidence and …

About 5% of Adults With RSV Experience Hospitalizations

Researchers quantified the real-world risk for hospitalization among adults diagnosed with respiratory syncytial virus (RSV) in outpatient settings in a study presented in JAMA Network Open. They examined all-cause 28-day hospitalization following outpatient RSV infections among all adults as well as a high-risk subgroup of adults across 6 RSV seasons comprising 67,239 outpatient infections. Data revealed approximately 5% of adults experienced all-cause hospitalization within 28 days following outpatient RSV infections. The analysis showed an absolute …

All Adults Over 75 Should Get RSV Vaccine: CDC

The Centers for Disease Control and Prevention (CDC) recently updated vaccine guidance after its advisory committee recommended that all adults aged 75 years and older and adults aged 60–74 years who are at increased risk should receive a single dose of a respiratory syncytial virus (RSV) vaccine. The update reflects CDC’s intent to maximize RSV vaccination coverage among those most likely to benefit and to reduce implementation barriers associated with a previous recommendation that called …

Abstracts in Urgent Care – March 2024

Omicron versus Flu & RSV – Which is Most Dangerous for Children? Take Home Point: In this study, hospitalization rates were highest for patients with RSV than Omicron (COVID-19) in all age groups of children. Citation: Hedberg P, Abdel-Halem L, Valik J, et. al. Outcomes of Pediatric SARS-CoV-2 Omicron Infection vs Influenza and Respiratory Syncytial Virus Infections. JAMA Pediatr. 2023 Dec 26: e235734. doi: 10.1001/jamapediatrics.2023.5734 Relevance: With increasing availability for respiratory pathogen testing, it is …

Texas UC Centers Managing Surge in Respiratory Illnesses

Urgent care centers and emergency departments (EDs) in Cook Children’s Medical Centers in Fort Worth and Prosper, Texas, are grappling with a sudden surge in RSV, influenza, and COVID-19. According to the medical center’s website, the hospitals are overwhelmed, struggling to accommodate infants with severe RSV cases. Last week, of the more than 800 RSV tests conducted, 29% were positive, while COVID-19 positivity stood at 4%. The medical center’s urgent care centers see about 800 …

New RSV Vaccine Recommended For Rationing by CDC

The Centers for Disease Control and Prevention (CDC) has recommended rationing nirsevimab, the new monoclonal antibody immunization product designed to protect infants from respiratory syncytial virus (RSV), due to strained supply nationwide. Because the supply challenges are occurring during the RSV season, CDC suggested on Monday in a health alert that providers should prioritize available nirsevimab 100 mg doses for infants of less than 6 months of age and infants with underlying conditions that place …

Abstracts in Urgent Care – May 2023

Does My Patient Have a Testicular Torsion? Take-home point: Symptoms most suggestive for testicular torsion (TT) are adolescent/pubertal age, palpated hard testicle, and the presence of nausea and vomiting associated with acute scrotal pain. Citation: Lukosiute-Urboniene A, Nekrosius D, Dekeryte I, et al. Clinical risk factors for testicular torsion and a warning against falsely reassuring ultrasound scans: a 10-year single-centre experience. Emerg Med J. 2023;40:134–139. Relevance: As symptoms of TT can be mimicked by other …